These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22406589)

  • 1. Locally advanced pancreatic adenocarcinoma: update and progress.
    Ng J; Zhang C; Gidea-Addeo D; Saif MW
    JOP; 2012 Mar; 13(2):155-8. PubMed ID: 22406589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of borderline resectable pancreatic adenocarcinoma.
    Jia Y; Wang TJ; Allendorf J; Saif MW
    JOP; 2012 Mar; 13(2):147-50. PubMed ID: 22406587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant strategies for resectable pancreatic cancer: have we made progress?
    Russo S; Jain AK; Saif MW
    JOP; 2012 Mar; 13(2):139-42. PubMed ID: 22406585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Locally advanced pancreatic adenocarcinoma: are we making progress?. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Li J; Ng J; Allendorf J; Saif MW
    JOP; 2011 Jul; 12(4):347-50. PubMed ID: 21737893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resectable pancreatic cancer: is surgery the best first step?
    Russo S; Chabot J; Saif MW
    JOP; 2012 Mar; 13(2):151-4. PubMed ID: 22406588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New tools and novel approaches in treating locally advanced pancreatic adenocarcinoma.
    Ahmed WB; Ng J; Wazer DE; Saif MW
    JOP; 2012 Jul; 13(4):354-7. PubMed ID: 22797388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
    Richter J; Saif MW
    JOP; 2010 Mar; 11(2):139-43. PubMed ID: 20208322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas.
    Sa Cunha A; Rault A; Laurent C; Adhoute X; Vendrely V; Béllannée G; Brunet R; Collet D; Masson B
    J Am Coll Surg; 2005 Sep; 201(3):359-65. PubMed ID: 16125068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant Therapy of Pancreatic Cancer. Highlights from the "2011 ASCO Annual Meeting". Chicago, IL, USA; June 3-7, 2011.
    Sharma C; Horowitz D; Chabot J; Saif MW
    JOP; 2011 Jul; 12(4):343-6. PubMed ID: 21737892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second line therapy for advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Brus C; Saif MW
    JOP; 2010 Jul; 11(4):321-3. PubMed ID: 20601802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An update on surgical staging of patients with pancreatic cancer.
    Winner M; Allendorf JD; Saif MW
    JOP; 2012 Mar; 13(2):143-6. PubMed ID: 22406586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New developments in the management of borderline resectable pancreatic cancer.
    Sharma J; Ng J; Goodman MD; Saif MW
    JOP; 2013 Mar; 14(2):123-5. PubMed ID: 23474551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant treatment for resectable pancreatic cancer.
    Chua YJ; Cunningham D
    J Clin Oncol; 2005 Jul; 23(20):4532-7. PubMed ID: 16002844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapy of locally advanced pancreatic adenocarcinoma: unresectable and borderline patients.
    Kircher SM; Krantz SB; Nimeiri HS; Mulcahy MF; Munshi HG; Benson AB
    Expert Rev Anticancer Ther; 2011 Oct; 11(10):1555-65. PubMed ID: 21999129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updates in locally advanced pancreatic cancer. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Chang BW; Siccion E; Saif MW
    JOP; 2010 Jul; 11(4):313-6. PubMed ID: 20601800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival effects of adjuvant chemoradiotherapy after resection for pancreatic carcinoma.
    Yang R; Cheung MC; Byrne MM; Jin X; Montero AJ; Jones C; Koniaris LG
    Arch Surg; 2010 Jan; 145(1):49-56. PubMed ID: 20083754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic neoplasm in 2011: an update.
    Saif MW
    JOP; 2011 Jul; 12(4):316-21. PubMed ID: 21737886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma of the pancreas: the rationale for neoadjuvant therapy.
    Sperti C; Pasquali C; Pastorelli D; Ferronato A; Decet G; Pedrazzoli S
    Acta Biomed; 2003; 74 Suppl 2():91-5. PubMed ID: 15055044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Up-to-date diagnosis and treatment of advanced pancreatic cancer].
    Stieler JM; Oettle H
    Dtsch Med Wochenschr; 2005 Sep; 130(38):2146-8. PubMed ID: 16172956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.